TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.6 CNY | +0.49% |
|
+2.81% | -2.50% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The Company conducts its businesses primarily in South China, North China, East China, Central China and overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-14
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
36.6
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.50% | 1.62B | |
| +25.97% | 661B | |
| +26.74% | 566B | |
| -6.65% | 352B | |
| +19.35% | 332B | |
| +3.35% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.22% | 145B |
- Stock Market
- Equities
- 600211 Stock
- News Tibet Rhodiola Pharmaceutical Holding Co.
- Tibet Rhodiola Pharma Wins License to Produce Chest Pain Tablets
